The streaming giant is critical for legacy catalogs, but it's plagued by unofficial uploads and poor-quality bootlegs. Here's how to cut through the noise. In today’s music business, the race to ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

YouTube has evolved from its humble origins to become a comprehensive video search engine and an extension of Google. As the number of users on the platform has grown, more content creators are using ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...